Stay updated on Durvalumab in Resectable Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Durvalumab in Resectable Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab in Resectable Lung Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The study record history now shows a new revision entry, v3.6.3, superseding the previous v3.6.2. This indicates an update to the record's content or metadata.
    Difference
    0.1%
    Check dated 2026-07-05T04:40:23.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    - The page's revision label updated from v3.6.0 to v3.6.2 in the record history. This change indicates a newer version of the page's history UI and does not alter the study data, eligibility, status, or presented content.
    Difference
    0.1%
    Check dated 2026-06-27T02:58:06.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Recruitment status updated to 'no longer looking for participants', indicating that the study is not enrolling currently. The record now shows Revision: v3.6.0, replacing the previous Revision: v3.5.5.
    Difference
    0.2%
    Check dated 2026-06-12T16:37:33.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page's footer revision tag was updated from v3.5.4 to v3.5.5. This reflects a new release of the page's content without altering study data or core functionality.
    Difference
    0.1%
    Check dated 2026-06-05T13:19:47.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    A new revision entry v3.5.4 was added to the record history, replacing the previous v3.5.3 entry and indicating a minor update in the page's version history.
    Difference
    0.1%
    Check dated 2026-05-15T04:53:49.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    New content sections Adverse Events and Outcome Measures (Results) were added to the study record history. The history also shows a Returned date of 2026-04-24 and a new Revision (v3.5.3) with QC status Has Not Concluded, replacing the prior Revision v3.5.2.
    Difference
    0.5%
    Check dated 2026-04-30T17:52:21.000Z thumbnail image

Stay in the know with updates to Durvalumab in Resectable Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab in Resectable Lung Cancer Clinical Trial page.